Tuesday, June 11, 2024

11:00 AM - 11:10 AM

210

---

Overview

Presented By: Dr. Sandra Yankah

---

Details

By the end of this session, participants will be able to: 1. Describe pharmacogenomic (PGx) testing, its clinical effectiveness, applications in psychiatric care, and the equity-related ethical considerations for its broader adoption. 2. Explain current regulatory approval process for PGx tests and review insurance coverage trends, highlighting the differences between public and private payers and their implications for patient access to PGx testing. 3. Identify and propose strategies to advance the responsible and equitable use of PGx testing in psychiatric care, aiming to improve patient outcomes and bridge the gap in mental health treatment, especially for underserved populations.

---

Speaker